View drug registration information details.
| Items | Registration information |
|---|
| ID | 966 |
|---|
| No | 966 |
|---|
| Brand Name | PEMIMAKS |
|---|
| Ingredients | PEMIGATINIB 4.5 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | 42 TABLETS/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | CHOLANGIOCARCINOMA, MYELOID/LYMPHOID NEOPLASM WITH FGFR1 REARRANGEMENT |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | WHITE, ROUND, TABLET |
|---|
| Note | |
|---|
| License Owner | FACTORY NO.2 |
|---|
| Manufacturer | FACTORY No.2 |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 01 L 1058/24 |
|---|
| FDD Registration Date | 31-JAN-2024 |
|---|
| Expiry Date | 30-JAN-2027 |
|---|
Back to drug list
|
